Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sean Cleary is a leading figure in the advancement of minimally invasive hepato-pancreato-biliary (HPB) surgery, with a focused research agenda on overcoming barriers to adoption and ensuring equitable access to these complex techniques. His work critically examines the systemic and technical challenges that limit the widespread use of laparoscopic and robotic approaches in liver and pancreatic surgery. Dr. Cleary’s major contributions include the development and external validation of the Tampa Difficulty Scoring System for robotic liver resections, a tool that standardizes case complexity assessment and enhances surgical planning. This work, validated through the Americas Minimally Invasive Liver Surgery Registry (AMILES), has been cited in emerging literature, reflecting its growing influence on clinical practice. With recent publications accumulating over a dozen citations in just two years, his research is already shaping the conversation around surgical innovation and health equity. Dr. Cleary’s efforts are pivotal in making advanced HPB procedures safer and more accessible, positioning him as a key voice in the next generation of surgical oncology.